Xaria initially joined the Woodruff Group - Neuroinflammation in July 2016. Upon graduating with First Class Honours, she undertook and recently completed her PhD (2021) investigating the immunopharmacology of the complement C5a receptors, C5aR1 and C5aR2. Her current research focuses on C5a immunomodulation towards other innate immune receptors and their roles in inflammatory diseases.